$UHS

UNIVERSAL HEALTH SERVICES INC

2
0
0

No SEC Form 4 filings for $UHS in the last 30 days.

See all $UHS insider activity →
Med

Universal Health Services Stock: Analyst Estimates & Ratings

Analysts covering Universal Health Services (UHS) have a consensus rating of 'Moderate Buy,' with six 'Strong Buy' ratings, 13 'Holds,' and one 'Moderate Sell.' The sentiment has shifted from seven 'Moderate Buy' ratings two months ago. RBC Capital analyst Ben Hendrix maintained a 'Sector-Perform' rating, lowering the price target to $183 from $190, implying a 7.3% upside. The mean price target is $192.24, a 9% premium to the current price, while the highest target is $290, suggesting a 64.4% up

This Week's Top 5: Beiersdorf, Centene, AXA Health and UHS

Beiersdorf will launch acne products with TopiC.A, a probiotic-based ingredient. Centene announces CFO Drew Asher's departure in 2027, succeeded by Chris Neczypor. Eli Lilly expands AI partnership with Veeva Systems. AXA appoints Dr. Melissa Castro as Chief Medical Advisor for AXA Health International. UHS completes acquisition of Talkspace, aiming to expand behavioral healthcare services.

UNIVERSAL HEALTH SERVICES INC (UHS): Entry into a Material Definitive Agreement

UNIVERSAL HEALTH SERVICES INC (UHS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement Issuance of Senior Secured Notes On August 20, 2026, Universal Health Services, Inc. (the “Issuer”), completed the public offering of (i) $600,000,000 aggregate principal amount of its 5.500% Senior Secured Notes due 2031 (the

UHS sentiment & insider activity

Over the past 7 days, alphai's AI scored 2 news stories mentioning UHS (UNIVERSAL HEALTH SERVICES INC). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.

Recent UHS coverage spans corporate actions, mergers & acquisitions and financial news.

What's driving UHS

alphai scores every news story that mentions UHS with an AI model for sentiment and relevance, and aggregates insider trades from UNIVERSAL HEALTH SERVICES INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $UHS

Score
$UHSMed

Universal Health Services Stock: Analyst Estimates & Ratings

Analysts covering Universal Health Services (UHS) have a consensus rating of 'Moderate Buy,' with six 'Strong Buy' ratings, 13 'Holds,' and one 'Moderate Sell.' The sentiment has shifted from seven 'Moderate Buy' ratings two months ago. RBC Capital analyst Ben Hendrix maintained a 'Sector-Perform' rating, lowering the price target to $183 from $190, implying a 7.3% upside. The mean price target is $192.24, a 9% premium to the current price, while the highest target is $290, suggesting a 64.4% up

This Week's Top 5: Beiersdorf, Centene, AXA Health and UHS

Beiersdorf will launch acne products with TopiC.A, a probiotic-based ingredient. Centene announces CFO Drew Asher's departure in 2027, succeeded by Chris Neczypor. Eli Lilly expands AI partnership with Veeva Systems. AXA appoints Dr. Melissa Castro as Chief Medical Advisor for AXA Health International. UHS completes acquisition of Talkspace, aiming to expand behavioral healthcare services.

$UHSHigh

UNIVERSAL HEALTH SERVICES INC (UHS): Entry into a Material Definitive Agreement

UNIVERSAL HEALTH SERVICES INC (UHS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement Issuance of Senior Secured Notes On August 20, 2026, Universal Health Services, Inc. (the “Issuer”), completed the public offering of (i) $600,000,000 aggregate principal amount of its 5.500% Senior Secured Notes due 2031 (the

$UHSMedAI 8/10

Universal Health Shares Drop 21% YTD: Should You Buy Now?

Universal Health Services (UHS) shares have dropped 20.9% YTD, underperforming peers and the S&P 500. Q2 volumes fell 15% YoY, leading to lowered 2026 guidance. Analysts expect 6.2% EPS growth in 2026. UHS trades at a forward P/E of 7.16X, below peers. The stock has upside potential but faces execution and policy risks.

$UHSMedAI 8/10

Does UHS’s Debt-Funded Talkspace Deal Reshape the Bull Case For Its Digital Behavioral Health Pivot?

Universal Health Services (UHS) completed $1.10 billion in bond offerings and a $26.64 million stock registration. It also used a $400 million loan and revolving credit to acquire Talkspace, increasing its focus on digital behavioral health. The debt-funded deal raises concerns about leverage amid forecasted earnings softness and operational integration risks.

$UHSMedAI 8/10

UHS Adds Talkspace to Accelerate Virtual Behavioral Health Growth

Universal Health Services (UHS) completed its acquisition of Talkspace for $835M, adding 6,000 therapists and expanding virtual behavioral health services. UHS expects the deal to be slightly accretive to EPS within 12 months, with greater benefits thereafter. UHS shares have fallen 6.6% over the past year, underperforming the industry. Talkspace's digital platform complements UHS's in-person care, offering growth opportunities in virtual higher-acuity services.

$UHSMed

UNIVERSAL HEALTH SERVICES INC (UHS): Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNIVERSAL HEALTH SERVICES INC (UHS) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Exhibit 99.1 Universal Health Services, Inc. Completes Acquisition of Talkspace, Inc. Creates nation's first full continuum of behavioral healthcare services, supporting people across every stage of their mental health journey KING OF PRUSSIA, PA and NEW YORK, NY (Aug. 17, 2026)

$UHSMed

UNIVERSAL HEALTH SERVICES INC (UHS): Entry into a Material Definitive Agreement

UNIVERSAL HEALTH SERVICES INC (UHS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement On August 11, 2026, Universal Health Services, Inc. (the “Issuer”) and certain of its subsidiaries entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, BofA Securities, Inc., Tr

The Bull Case For Universal Health Services (UHS) Could Change Following Big Q2 Earnings Beat And Buyback Completion - Learn Why

Simply Wall St says Universal Health Services (UHS) reported Q2 2026 revenue of $4,638.01 million and net income of $358.45 million. It also states UHS repurchased 1,890,000 shares for $320.3 million from Apr 1 to Jun 30, completing a roughly $6.62 billion buyback and reducing the share count. The piece cites analyst forecasts for 2029 revenue of about $20.7 billion and earnings of $1.5 billion.

Related tickers